Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
International Journal of Obesity
|
January 1, 1986
Renal function in the obese Zucker rat
W D Fiske, R A Blouin, B Mitchell, et al.
AIDS (London, England)
|
June 15, 2000
Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis
M J Gill, N J Ostrop, W D Fiske, et al.
Clinical Pharmacology and Therapeutics
|
April 29, 1998
Pharmacodynamics and pharmacokinetics of DMP 728, a platelet GPIIb/IIIa antagonist, in healthy subjects
W Michaelis, P Turlapaty, J Gray, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 18, 2003
Population pharmacokinetic meta-analysis with efavirenz
J S Barrett, A S Joshi, M Chai, et al.
British Journal of Clinical Pharmacology
|
December 1, 1983
Serum alpha 1-acid glycoprotein and the binding of drugs in obesity
I H Benedek, W D Fiske, W O Griffen, et al.
Journal of Clinical Pharmacology
|
January 1, 1995
Single-dose pharmacokinetics, safety, and tolerance of linopirdine (DuP 996) in healthy young adults and elderly volunteers
H J Pieniaszek, W D Fiske, T D Saxton, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1984
Physiological model for distribution of sulfathiazole in swine
J Duddy, T L Hayden, D W Bourne, et al.
The Journal of Infectious Diseases
|
August 7, 1999
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy
K T Tashima, A M Caliendo, M Ahmad, et al.
Journal of Pharmaceutical Sciences
|
June 2, 2007
Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz)
J Zh Gao, M A Hussain, R Motheram, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
International Journal of Obesity
|
January 1, 1986
Renal function in the obese Zucker rat
W D Fiske, R A Blouin, B Mitchell, et al.
AIDS (London, England)
|
June 15, 2000
Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis
M J Gill, N J Ostrop, W D Fiske, et al.
Clinical Pharmacology and Therapeutics
|
April 29, 1998
Pharmacodynamics and pharmacokinetics of DMP 728, a platelet GPIIb/IIIa antagonist, in healthy subjects
W Michaelis, P Turlapaty, J Gray, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 18, 2003
Population pharmacokinetic meta-analysis with efavirenz
J S Barrett, A S Joshi, M Chai, et al.
British Journal of Clinical Pharmacology
|
December 1, 1983
Serum alpha 1-acid glycoprotein and the binding of drugs in obesity
I H Benedek, W D Fiske, W O Griffen, et al.
Journal of Clinical Pharmacology
|
January 1, 1995
Single-dose pharmacokinetics, safety, and tolerance of linopirdine (DuP 996) in healthy young adults and elderly volunteers
H J Pieniaszek, W D Fiske, T D Saxton, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1984
Physiological model for distribution of sulfathiazole in swine
J Duddy, T L Hayden, D W Bourne, et al.
The Journal of Infectious Diseases
|
August 7, 1999
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy
K T Tashima, A M Caliendo, M Ahmad, et al.
Journal of Pharmaceutical Sciences
|
June 2, 2007
Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz)
J Zh Gao, M A Hussain, R Motheram, et al.
Page
of 1